The joint ABCD-UKKA committee seeks to improve the care of people with diabetic kidney disease (DKD) by the following actions: Creation and regular updating of treatment guidelines, with a specific focus on the National Health Service (NHS) and medicines licensed for use in the UK promotion of the use of these treatment guidelines by the clinical community.
Joint Clinical Practice Guidelines for the Pharmacological Management of Hyperglycemia in Adults With Type 2 Diabetes Mellitus and CKD
ABCD and UK Kidney Association (UKKA) Diabetic Kidney Disease Clinical Speciality Group have previously undertaken a narrative review and critical appraisal of the available evidence to inform clinical practice guidelines for the pharmacological management of hyperglycemia in adults with T2DM and CKD. This 2025 abbreviated updated guidance by a multidisciplinary group of health care professionals from primary and secondary care settings summarizes the key recommendations, clinical considerations and recent evidence that has implications for clinical practice for health care professionals who treat people with T2DM and CKD.
Resource taxonomy
Clinical taxonomy
Listing status
Published
2025
